Reduced Mortality Risk Seen for Coffee Drinkers

This article originally appeared here.
Share this content:
Reduced Mortality Risk Seen for Coffee Drinkers
Reduced Mortality Risk Seen for Coffee Drinkers

TUESDAY, Nov. 17, 2015 (HealthDay News) -- People who drink coffee may live longer than those who don't -- with lower risks of early mortality from cardiovascular disease and neurological conditions such as Parkinson's disease, according to research published online Nov. 16 in Circulation.

Frank Hu, M.D., Ph.D., a professor of nutrition and epidemiology at the Harvard School of Public Health in Boston, and colleagues based their findings on 208,501 U.S. doctors, nurses, and other health professionals who were surveyed repeatedly over almost three decades. During that time, 31,956 study participants died.

Over 30 years, nonsmokers who drank three to five cups of coffee a day were 15 percent less likely to die of any cause, versus nondrinkers. Specifically, they had lower rates of mortality from cardiovascular disease, stroke, neurological conditions, and suicide. Both regular coffee and decaf were linked to longer survival, the researchers found.

The relationship grew stronger when the researchers looked only at nonsmokers: Those who drank three to five cups of coffee a day were 15 percent less likely to die during the study period, compared with adults who didn't drink coffee. Lower risks were even seen among the heaviest coffee drinkers (more than five cups a day), who had a 12 percent lower mortality risk than nondrinkers.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »